Last updated on March 2019

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo


Brief description of study

Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.

Clinical Study Identifier: NCT00351611

Contact Investigators or Research Sites near you

Start Over

Minneapolis Clinic of Neurology, Ltd

Golden Valley, MN United States
4.95miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.